Do exosomes play role in cardiovascular disease development in hematological malignancy?
Angiogenesis
Cardiovascular disease
Exosome
Hematological malignancy
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
18
01
2020
accepted:
09
04
2020
pubmed:
23
4
2020
medline:
8
6
2021
entrez:
23
4
2020
Statut:
ppublish
Résumé
Exosomes play a role in the pathogenesis and treatment of malignancies as a double-edged sword. Recently, researchers discussed about two new roles, cardiomyocyte function impairment and cardiovascular disease (CVD) genesis. Data were collected from PUBMED at various time points up to the 2019 academic year. The related key words are listed as following; "Arsenic trioxide", "acute promyelocytic leukemia" and "cardio toxicity" and "molecular pathway" and "biomarker". This study has shown that exosomes secreted substances stimulate angiogenesis and cardiomyocytes repairment; cited process depended on the kinds of released substances. Generally, exosomes may involve in the pathogenesis of CVD; although CVD can prevented by identifying the pathways that induce angiogenesis.
Identifiants
pubmed: 32319009
doi: 10.1007/s11033-020-05453-z
pii: 10.1007/s11033-020-05453-z
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM